Does L8682 require prior authorization?

Yes, L8682 requires prior authorization (high confidence). At least one active policy explicitly requires prior authorization.

Backwork Sign up free

`L8682`, Implantable neurostimulator radiofrequency receiver

HCPCS/CPT

Prior Authorization

Prior Auth Required

At least one active policy explicitly requires prior authorization (high confidence)

Documentation Required

Claims may require medical records documentation to assess whether the member meets the clinical criteria for coverage; however, documentation does not guarantee coverage.
Imaging and laboratory/biomarker data used in studies: brain CT or MRI, amyloid PET (e.g., florbetapir), cerebrospinal fluid (CSF) biomarkers (Aβ1-42, total tau, phospho-tau), and APOE ε4 genotyping when reported in trials.
For some interventional procedures/trials, pre-procedure evaluations included medical/neurological and psychological examinations, depression rating scales (e.g., Montgomery–Asberg Depression Rating Scale), and lumbar puncture with CSF analysis.
Documentation of prior/concurrent standard therapies (e.g., use of cholinesterase inhibitors and/or memantine) is often recorded in trials and may be relevant when considering investigational add-on therapies.
None specified in this policy document. (The CPB lists investigational/experimental treatments and codes not covered; it does not define separate documentation requirements for coverage of the listed items.)
None specified in this document excerpt.

Key Coverage Criteria

Deep brain stimulation is proven and medically necessary for treating dystonia, essential tremor, Parkinson disease, and refractory epilepsy for a partial or focal seizure disorder.
Covered indication: Implanted electrical spinal cord stimulators are medically necessary for CRPS, painful diabetic neuropathy, and failed back surgery syndrome when performed per FDA-labeled indications and cautions.
Sacral Nerve Stimulation (neurostimulation) screening trial is proven and medically necessary for treating urinary voiding dysfunction when all the following criteria are met: Lower urinary tract symptoms, as indicated by one or more of the following: Overactive bladder symptoms, Urge Incontinence, Nonobstructive urinary retention; Bladder capacity ≥100 mL; No neurologic cause; No bladder outlet obstruction; Symptoms refractory to conservative care; Individual capable of operating the device.
Implantable vagus nerve stimulators are proven and medically necessary for treating epilepsy in individuals who have medically refractory seizures with failure of two or more trials of antiseizure drugs (or intolerable AED effects), are not candidates for epilepsy surgery (or have failed/refuse after shared decision making), and have no history of left or bilateral cervical vagotomy.
None specified. This Clinical Policy Bulletin addresses experimental treatments for Alzheimer's disease and lists treatments considered experimental and investigational (i.e., not established as effective) for this indication.
No explicit covered indications are stated in this document. The document discusses potential therapeutic use in the following conditions:

20 Active Policies

ANTHEM-SURG.00026, Deep Brain, Cortical, and Cerebellar Stimulation

ANTHEM-CG-SURG-95, Sacral Nerve Stimulation for Urinary Retention, Urinary Incontinence, and Fecal Incontinence

ANTHEM-CG-MED-79, Diaphragmatic/Phrenic Nerve Stimulation and Diaphragm Pacing Systems

EVICORE-HPLAN-CIGNA-AFCE721BA4F3, Cigna Comprehensive Code List - Effective 03/07/2026

EVICORE-HPLAN-CIGNA-844835841DE9, Cigna Commercial Interventional Pain Management Code List - Effective 03/07/2026

EVICORE-HPLAN-CIGNA_MEDICARE-47F76AA38AE6, Cigna Medicare Advantage Interventional Pain Management Code List - Effective 01/01/2025

CARELON-interventional-pain-management-2024-06-30-for-ohio-medicaid, Interventional Pain Management

CARELON-interventional-pain-management-2025-07-26-for-anthem-bc-ca-commercial, Interventional Pain Management

CARELON-interventional-pain-management-2026-06-14, Interventional Pain Management

UHC-POL-deep-brain-cortical-stimulation, Deep Brain and Cortical Stimulation

UHC-POL-electrical-stimulation-treatment-pain-muscle-rehabilitation, Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation

UHC-POL-implanted-electrical-stimulator-spinal-cord, Implanted Electrical Stimulator for the Spinal Cord

UHC-POL-sacral-nerve-stimulation, Sacral Nerve Stimulation for Urinary and Fecal Indications

UHC-POL-vagus-nerve-stimulation, Vagus and External Trigeminal Nerve Stimulation

AETNA-CPB-0788, Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments

AETNA-CPB-0707, Headaches: Invasive Procedures

AETNA-CPB-0253, Vocal Cord Paralysis / Insufficiency Treatments

AETNA-CPB-0755, Motor Cortex Stimulation

AETNA-CPB-0378, NeuroControl Freehand System

UHCMA-POL-UHC_MA-deep-brain-responsive-cortical-stimulation, Deep Brain and Responsive Cortical Stimulation

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about L8682 Sign up free

L8682, Implantable neurostimulator radiofrequency receiver